BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10342095)

  • 21. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The androgenicity of oral contraceptives: the young patient's concerns.
    Runnebaum B
    Int J Fertil; 1992; 37 Suppl 4():211-7. PubMed ID: 1362188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraceptive use in perimenopause.
    Kaunitz AM
    Am J Obstet Gynecol; 2001 Aug; 185(2 Suppl):S32-7. PubMed ID: 11521120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-contraceptive benefits of oral contraceptives.
    Prog Hum Reprod Res; 1996; (39):6-7. PubMed ID: 12292200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinician/patient interaction: communicating the benefits and risks of oral contraceptives.
    Davis A; Wysocki S
    Contraception; 1999 Jan; 59(1 Suppl):39S-42S. PubMed ID: 10342096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of endometriosis: a hormonal approach.
    Budinetz T; Sanfilippo JS
    Minerva Ginecol; 2010 Aug; 62(4):373-80. PubMed ID: 20827253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal contraception and ovarian pathology.
    Crosignani PG; Vegetti W; Bianchedi D
    Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):207-11. PubMed ID: 9678075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives for the prevention of osteoporosis.
    Corson SL
    J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncontraceptive uses of hormonal contraception.
    King J
    J Midwifery Womens Health; 2011; 56(6):628-35. PubMed ID: 22060223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits and risks of oral contraceptive use.
    Williams RS
    Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mothers' attitude to the use of a combined oral contraceptive pill by their daughters for menstrual disorders or contraception.
    Yiu KW; Chan SS; Chung TK
    Hong Kong Med J; 2017 Apr; 23(2):150-7. PubMed ID: 28232640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
    Gambacciani M; Cappagli B; Ciaponi M; Benussi C; Genazzani AR
    Menopause; 1999; 6(1):43-8. PubMed ID: 10100179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents.
    Sabatini R; Orsini G; Cagiano R; Loverro G
    Contraception; 2007 Nov; 76(5):342-7. PubMed ID: 17963857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional ovarian cysts in premenopausal and gynecologically healthy women.
    Christensen JT; Boldsen JL; Westergaard JG
    Contraception; 2002 Sep; 66(3):153-7. PubMed ID: 12384202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis.
    Chapron C; Souza C; Borghese B; Lafay-Pillet MC; Santulli P; Bijaoui G; Goffinet F; de Ziegler D
    Hum Reprod; 2011 Aug; 26(8):2028-35. PubMed ID: 21642638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-contraceptive health benefits of oral contraceptives.
    Maia HJ; Casoy J
    Eur J Contracept Reprod Health Care; 2008 Mar; 13(1):17-24. PubMed ID: 17963179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysmenorrhea in adolescents and young adults: etiology and management.
    Harel Z
    J Pediatr Adolesc Gynecol; 2006 Dec; 19(6):363-71. PubMed ID: 17174824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.